Mesoblast Limited(NASDAQ:MESO) 
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine...
Website: http://www.mesoblast.com
Founded: 2004
Full Time Employees: 102
CEO: Silviu Itescu
Sector: Healthcare
Industry: Biotechnology
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
| Unit: USD | 2025-06-30 |
|---|
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2025-06-30 | 2024-12-31 | 2023-06-30 | 2023-05-26 | 2023-03-31 | 2023-02-28 | 2022-12-31 | 2022-11-28 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2015-12-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | ||||||||||||||||||||||||||
current assets | ||||||||||||||||||||||||||
cash & cash equivalents | 161,551,000 | 38,029,000 | 71,318,000 | 48,799,000 | 48,799,000 | 67,619,000 | 67,619,000 | 85,502,000 | 85,502,000 | 60,447,000 | 76,760,000 | 94,849,000 | 115,956,000 | 136,881,000 | 158,263,000 | 77,528,000 | 108,123,000 | 129,328,000 | 60,077,000 | 81,348,000 | 77,022,000 | 47,386,000 | 69,122,000 | 33,902,000 | 60,355,000 | |
trade & other receivables | 14,866,000 | 2,996,000 | 6,998,000 | 8,393,000 | 8,393,000 | 5,115,000 | 5,115,000 | 3,863,000 | 3,863,000 | 4,403,000 | 5,634,000 | 6,048,000 | 5,627,000 | 4,842,000 | 2,947,000 | 3,342,000 | 2,446,000 | 1,574,000 | 3,001,000 | 3,091,000 | 3,934,000 | 12,236,000 | 6,522,000 | 27,133,000 | 4,583,000 | |
prepayments | 5,687,000 | 4,460,000 | 3,342,000 | 4,173,000 | 4,173,000 | 5,399,000 | 5,399,000 | 3,595,000 | 3,595,000 | 4,987,000 | 5,739,000 | 7,900,000 | 4,637,000 | 6,504,000 | 8,556,000 | 9,588,000 | 5,168,000 | 5,646,000 | 6,315,000 | 8,868,000 | 16,845,000 | 12,650,000 | 10,828,000 | 5,966,000 | 5,759,000 | 7,872,000 |
inventory | 22,246,000 | 24,194,000 | ||||||||||||||||||||||||
total current assets | 204,350,000 | 69,679,000 | 81,658,000 | 61,365,000 | 61,365,000 | 78,133,000 | 78,133,000 | 92,960,000 | 92,960,000 | 69,837,000 | 88,133,000 | 108,797,000 | 126,220,000 | 148,227,000 | 169,766,000 | 90,458,000 | 115,737,000 | 136,548,000 | 69,393,000 | 93,307,000 | 97,801,000 | 72,272,000 | 86,472,000 | 67,001,000 | 70,697,000 | 94,004,000 |
non-current assets | ||||||||||||||||||||||||||
property, plant and equipment | 1,702,000 | 1,004,000 | 1,357,000 | 1,484,000 | 1,484,000 | 1,556,000 | 1,556,000 | 1,786,000 | 1,786,000 | 2,045,000 | 2,243,000 | 2,470,000 | 2,750,000 | 3,021,000 | 2,989,000 | 3,237,000 | 2,294,000 | 2,293,000 | 1,965,000 | 1,554,000 | 871,000 | 1,453,000 | 2,153,000 | 2,485,000 | 2,925,000 | 3,990,000 |
right-of-use assets | 4,121,000 | 5,215,000 | 5,134,000 | 5,641,000 | 5,641,000 | 6,598,000 | 6,598,000 | 7,730,000 | 7,730,000 | 7,920,000 | 8,363,000 | 9,033,000 | 8,485,000 | 9,119,000 | 7,247,000 | 7,176,000 | 8,038,000 | 7,978,000 | 7,479,000 | 8,042,000 | ||||||
financial assets at fair value through other comprehensive income | 1,388,000 | 1,208,000 | 1,757,000 | 2,032,000 | 2,032,000 | 1,949,000 | 1,949,000 | 1,843,000 | 1,843,000 | 1,758,000 | 2,032,000 | 2,347,000 | 2,234,000 | 2,080,000 | 1,981,000 | 1,899,000 | 1,952,000 | 1,871,000 | 1,766,000 | 1,672,000 | 2,516,000 | |||||
other non-current assets | 1,296,000 | 1,333,000 | 2,326,000 | 2,388,000 | 2,388,000 | 1,922,000 | 1,922,000 | 1,902,000 | 1,902,000 | 1,930,000 | 1,973,000 | 1,956,000 | 1,952,000 | 1,724,000 | 3,203,000 | 3,210,000 | 3,334,000 | 3,311,000 | 3,244,000 | 3,324,000 | 3,330,000 | 3,399,000 | 1,911,000 | 2,325,000 | 2,362,000 | 2,302,000 |
intangible assets | 571,826,000 | 574,879,000 | 577,183,000 | 577,531,000 | 577,531,000 | 577,902,000 | 577,902,000 | 578,275,000 | 578,275,000 | 578,652,000 | 578,945,000 | 579,836,000 | 580,178,000 | 580,546,000 | 580,939,000 | 581,330,000 | 581,217,000 | 581,601,000 | 581,943,000 | 582,338,000 | 583,815,000 | 585,622,000 | 586,713,000 | 587,072,000 | 587,463,000 | 650,271,000 |
total non-current assets | 580,333,000 | 583,639,000 | 587,757,000 | 589,076,000 | 589,076,000 | 589,927,000 | 589,927,000 | 591,536,000 | 591,536,000 | 592,305,000 | 593,556,000 | 595,642,000 | 595,599,000 | 596,490,000 | 596,359,000 | 596,852,000 | 596,835,000 | 597,054,000 | 596,397,000 | 596,930,000 | 590,532,000 | 592,539,000 | 592,688,000 | 593,879,000 | 594,747,000 | 658,863,000 |
total assets | 784,683,000 | 653,318,000 | 669,415,000 | 650,441,000 | 650,441,000 | 668,060,000 | 668,060,000 | 684,496,000 | 684,496,000 | 662,142,000 | 681,689,000 | 704,439,000 | 721,819,000 | 744,717,000 | 766,125,000 | 687,310,000 | 712,572,000 | 733,602,000 | 665,790,000 | 690,237,000 | 688,333,000 | 664,811,000 | 679,160,000 | 660,880,000 | 665,444,000 | 752,867,000 |
liabilities | ||||||||||||||||||||||||||
current liabilities | ||||||||||||||||||||||||||
trade and other payables | 19,082,000 | 11,860,000 | 20,145,000 | 20,972,000 | 20,972,000 | 22,992,000 | 22,992,000 | 17,663,000 | 17,663,000 | 23,079,000 | 18,983,000 | 20,919,000 | 16,263,000 | 19,598,000 | 24,275,000 | 28,610,000 | 27,602,000 | 24,972,000 | 19,478,000 | 19,241,000 | 25,120,000 | 18,121,000 | 26,169,000 | 26,259,000 | 28,119,000 | 23,558,000 |
provisions and other liabilities | 20,985,000 | |||||||||||||||||||||||||
borrowings | 54,155,000 | 17,505,000 | 5,952,000 | 7,314,000 | 7,314,000 | 5,938,000 | 5,938,000 | 5,489,000 | 5,489,000 | 5,017,000 | 5,523,000 | 5,203,000 | 53,847,000 | 53,200,000 | 52,673,000 | 41,571,000 | 34,893,000 | 32,455,000 | 27,000,000 | 18,928,000 | 3,095,000 | |||||
lease liabilities | 2,680,000 | 2,381,000 | 4,060,000 | 3,605,000 | 3,605,000 | 3,860,000 | 3,860,000 | 3,609,000 | 3,609,000 | 3,186,000 | 2,431,000 | 3,489,000 | 3,140,000 | 2,765,000 | 2,841,000 | 2,552,000 | 2,984,000 | 3,519,000 | 3,059,000 | 2,691,000 | ||||||
warrant liability | 5,724,000 | 13,437,000 | 5,426,000 | 4,450,000 | 4,450,000 | 3,933,000 | 3,933,000 | 2,586,000 | 2,586,000 | 2,185,000 | 5,033,000 | 6,055,000 | ||||||||||||||
total current liabilities | 102,626,000 | 72,750,000 | 41,982,000 | 53,917,000 | 53,917,000 | 54,576,000 | 54,576,000 | 48,802,000 | 48,802,000 | 51,373,000 | 52,186,000 | 57,954,000 | 92,899,000 | 94,273,000 | 98,546,000 | 91,040,000 | 87,697,000 | 90,143,000 | 76,689,000 | 76,957,000 | 33,809,000 | 21,591,000 | 29,661,000 | 29,099,000 | 31,321,000 | 40,400,000 |
non-current liabilities | ||||||||||||||||||||||||||
deferred consideration | 2,500,000 | 2,500,000 | 2,500,000 | 2,500,000 | 2,500,000 | 2,500,000 | 2,500,000 | 2,500,000 | 2,500,000 | 2,500,000 | 2,500,000 | 2,500,000 | 2,500,000 | 2,500,000 | 2,500,000 | 2,500,000 | 2,500,000 | 10,000,000 | 10,000,000 | |||||||
total non-current liabilities | 84,615,000 | 119,306,000 | 125,595,000 | 114,356,000 | 114,356,000 | 113,482,000 | 113,482,000 | 112,887,000 | 112,887,000 | 113,725,000 | 112,376,000 | 110,976,000 | 69,174,000 | 69,047,000 | 66,649,000 | 77,539,000 | 86,369,000 | 94,133,000 | 101,288,000 | 112,476,000 | 129,967,000 | 67,615,000 | 109,098,000 | 121,264,000 | 124,251,000 | 259,641,000 |
total liabilities | 187,241,000 | 192,056,000 | 167,577,000 | 168,273,000 | 168,273,000 | 168,058,000 | 168,058,000 | 161,689,000 | 161,689,000 | 165,098,000 | 164,562,000 | 168,930,000 | 162,073,000 | 163,320,000 | 165,195,000 | 168,579,000 | 174,066,000 | 184,276,000 | 177,977,000 | 189,433,000 | 163,776,000 | 89,206,000 | 138,759,000 | 150,363,000 | 155,572,000 | 300,041,000 |
net assets | 597,442,000 | 461,262,000 | 501,838,000 | 482,168,000 | 482,168,000 | 500,002,000 | 500,002,000 | 522,807,000 | 522,807,000 | 497,044,000 | 517,127,000 | 535,509,000 | 559,746,000 | 581,397,000 | 600,930,000 | 518,731,000 | 538,506,000 | 549,326,000 | 487,813,000 | 500,804,000 | 524,557,000 | 575,605,000 | 540,401,000 | 510,517,000 | 509,872,000 | 452,826,000 |
equity | ||||||||||||||||||||||||||
issued capital | 1,508,846,000 | 1,320,207,000 | 1,249,123,000 | 1,207,500,000 | 1,207,500,000 | 1,207,714,000 | 1,207,714,000 | 1,207,734,000 | 1,207,734,000 | 1,165,309,000 | 1,165,309,000 | 1,163,586,000 | 1,163,492,000 | 1,163,153,000 | 1,162,188,000 | 1,065,539,000 | 1,063,005,000 | 1,051,450,000 | 960,447,000 | 959,635,000 | 909,235,000 | 878,989,000 | 770,289,000 | 709,593,000 | ||
reserves | 99,499,000 | 97,750,000 | 73,520,000 | 73,554,000 | 73,554,000 | 72,574,000 | 72,574,000 | 70,873,000 | 70,873,000 | 70,651,000 | 69,279,000 | 68,082,000 | 66,468,000 | 65,813,000 | 64,251,000 | 52,186,000 | 48,803,000 | 46,634,000 | 43,514,000 | 42,054,000 | 39,617,000 | 34,837,000 | 27,991,000 | 26,665,000 | 27,468,000 | 20,353,000 |
accumulated losses | -1,010,903,000 | -820,805,000 | -277,120,000 | |||||||||||||||||||||||
total equity | 597,442,000 | 461,262,000 | 501,838,000 | 482,168,000 | 482,168,000 | 500,002,000 | 500,002,000 | 522,807,000 | 522,807,000 | 497,044,000 | 517,127,000 | 535,509,000 | 559,746,000 | 581,397,000 | 600,930,000 | 518,731,000 | 538,506,000 | 549,326,000 | 487,813,000 | 500,804,000 | 524,557,000 | 575,605,000 | 540,401,000 | 510,517,000 | 509,872,000 | 452,826,000 |
provisions | 27,567,000 | 6,399,000 | 17,576,000 | 17,576,000 | 17,853,000 | 17,853,000 | 19,455,000 | 19,455,000 | 17,906,000 | 20,216,000 | 22,288,000 | 19,649,000 | 18,710,000 | 18,757,000 | 18,307,000 | 22,218,000 | 29,197,000 | 27,152,000 | 26,097,000 | 5,594,000 | 3,470,000 | 3,492,000 | 2,840,000 | 3,202,000 | 1,838,000 | |
(accumulated losses)/retained earnings | -798,886,000 | -798,886,000 | -780,286,000 | -780,286,000 | -755,800,000 | -755,800,000 | -738,916,000 | -717,461,000 | -696,159,000 | -670,214,000 | -647,569,000 | -625,509,000 | -598,994,000 | -573,302,000 | -548,758,000 | -516,148,000 | -500,885,000 | -424,295,000 | -338,221,000 | -317,720,000 | -307,936,000 | -287,885,000 | ||||
deferred tax liability | 730,000 | 4,966,000 | 6,922,000 | 16,504,000 | 23,912,000 | 53,369,000 | 56,462,000 | 59,588,000 | 149,387,000 | |||||||||||||||||
available-for-sale financial assets | 2,065,000 | 1,911,000 | 1,997,000 | 1,997,000 | 2,300,000 | |||||||||||||||||||||
capital | 830,130,000 | 791,788,000 | ||||||||||||||||||||||||
cash and cash equivalents | 77,761,000 | |||||||||||||||||||||||||
trade and other receivables | 8,371,000 | |||||||||||||||||||||||||
deferred revenue | 15,004,000 |
Cashflow Statements:
Quarterly
Annual
| Unit: USD | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-11-28 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-09-30 | 2017-06-30 | 2016-09-30 | 2016-06-30 | 2015-12-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities | ||||||||||||||||||||||||||||
royalty revenue received | ||||||||||||||||||||||||||||
government grants and tax incentives and credits received | ||||||||||||||||||||||||||||
payments to suppliers and employees | -19,651,000 | -18,399,000 | -18,067,000 | -16,566,000 | -16,566,000 | -15,914,000 | -17,878,000 | -21,755,000 | -20,222,000 | -20,891,000 | -26,672,000 | -31,873,000 | -27,484,000 | -19,989,000 | -20,603,000 | -19,580,000 | -17,539,000 | -18,622,000 | -21,486,000 | -24,147,000 | -22,039,000 | -20,963,000 | -21,126,000 | -20,892,000 | -27,155,000 | -21,369,000 | -22,967,000 | -28,377,000 |
interest received | 397,000 | 192,000 | 147,000 | 60,000 | 60,000 | 2,000 | 1,000 | 0 | 4,000 | 0 | 1,000 | 3,000 | 13,000 | 13,000 | 120,000 | 240,000 | 173,000 | 233,000 | 200,000 | 157,000 | 136,000 | 101,000 | 74,000 | 63,000 | 88,000 | 181,000 | 313,000 | 288,000 |
income taxes (paid)/received | ||||||||||||||||||||||||||||
net cash (outflows) in operating activities | -16,278,000 | -16,250,000 | -16,454,000 | -14,287,000 | -14,287,000 | -13,894,000 | -15,470,000 | -16,812,000 | -19,606,000 | -20,730,000 | -25,822,000 | -31,962,000 | -28,167,000 | -19,582,000 | -19,895,000 | -1,330,000 | -15,558,000 | -19,086,000 | -21,189,000 | 2,029,000 | -19,544,000 | -20,188,000 | -19,603,000 | -20,356,000 | -23,435,000 | -20,827,000 | -18,089,000 | -28,067,000 |
cash flows from investing activities | ||||||||||||||||||||||||||||
payments for property, plant and equipment | ||||||||||||||||||||||||||||
receipts from investment in sublease | 53,000 | |||||||||||||||||||||||||||
receipt of security deposits | ||||||||||||||||||||||||||||
payments for licenses | -50,000 | -50,000 | -50,000 | 0 | 0 | -100,000 | 0 | -200,000 | ||||||||||||||||||||
net cash inflows/(outflows) in investing activities | ||||||||||||||||||||||||||||
cash flows from financing activities | ||||||||||||||||||||||||||||
repayment of borrowings | 0 | 0 | ||||||||||||||||||||||||||
payment of transaction costs from borrowings | -162,000 | -195,000 | -66,000 | -151,000 | -151,000 | -14,000 | -60,000 | |||||||||||||||||||||
interest and other costs of finance paid | -1,770,000 | -1,437,000 | -1,426,000 | -1,381,000 | -1,381,000 | -1,767,000 | -1,366,000 | -1,544,000 | -1,407,000 | -1,810,000 | -1,351,000 | -1,382,000 | -1,389,000 | -1,782,000 | -1,377,000 | -1,361,000 | -1,427,000 | |||||||||||
proceeds from issue of shares | 43,570,000 | 0 | 0 | 45,065,000 | 45,065,000 | 0 | 0 | 62,000 | 147,000 | 684,000 | 96,019,000 | 1,431,000 | 8,134,000 | 93,387,000 | 506,000 | 50,754,000 | 299,000 | 0 | 0 | 20,210,000 | 10,048,000 | 0 | 34,000 | 40,449,000 | 148,000 | 0 | 169,000 | |
proceeds from exercise of options | ||||||||||||||||||||||||||||
proceeds from issue of warrants | 0 | 0 | 0 | |||||||||||||||||||||||||
payments for share issue costs | -2,016,000 | -227,000 | -81,000 | -2,565,000 | -2,565,000 | -6,000 | 0 | -112,000 | -104,000 | -280,000 | -642,000 | -8,000 | -897,000 | -4,066,000 | -47,000 | -1,000 | 0 | -249,000 | -358,000 | -661,000 | -1,000 | -2,001,000 | -43,000 | -55,000 | 18,000 | |||
payments for lease liabilities | -865,000 | -682,000 | -439,000 | -670,000 | -670,000 | -429,000 | -1,145,000 | -528,000 | -686,000 | -831,000 | -620,000 | -785,000 | -695,000 | |||||||||||||||
net cash inflows by financing activities | -427,000 | 107,713,000 | 638,000 | 6,542,000 | 88,915,000 | -65,000 | 48,230,000 | -36,000 | -33,000 | 14,586,000 | 19,949,000 | 37,106,000 | -1,013,000 | 18,000 | 169,000 | |||||||||||||
net increase/(decrease) in cash and cash equivalents | 25,808,000 | -21,706,000 | -15,847,000 | 12,057,000 | 17,466,000 | |||||||||||||||||||||||
cash and cash equivalents at beginning of period | 0 | 0 | 0 | 60,447,000 | 60,447,000 | 0 | 0 | 0 | 136,881,000 | 0 | 0 | 0 | 129,328,000 | 0 | 0 | 0 | 50,426,000 | 0 | 0 | 0 | 37,763,000 | 0 | 0 | 45,761,000 | 0 | 80,937,000 | 0 | 110,701,000 |
foreign exchange gain/(loss) on the translation of foreign bank accounts | ||||||||||||||||||||||||||||
cash and cash equivalents at end of period | 22,519,000 | -18,820,000 | -17,883,000 | 85,502,000 | 85,502,000 | -16,313,000 | -18,089,000 | -21,107,000 | 115,956,000 | -21,382,000 | 80,735,000 | -30,595,000 | 108,123,000 | 69,251,000 | -21,271,000 | 46,812,000 | 34,536,000 | -19,959,000 | -6,637,000 | 21,879,000 | 55,143,000 | -21,776,000 | 12,153,000 | 62,941,000 | -23,361,000 | 60,355,000 | -18,992,000 | 77,761,000 |
commercialization revenue received | 1,834,000 | 1,979,000 | 1,448,000 | 2,219,000 | 2,219,000 | 2,011,000 | 2,438,000 | 3,536,000 | 1,995,000 | 1,959,000 | 2,190,000 | 1,290,000 | 682,000 | 2,097,000 | 1,969,000 | 1,871,000 | 1,739,000 | 1,038,000 | 1,220,000 | 1,006,000 | 1,095,000 | 490,000 | 1,449,000 | 474,000 | 320,000 | 361,000 | ||
income taxes paid | 7,000 | 0 | -29,000 | |||||||||||||||||||||||||
payments for intellectual property | 0 | -49,000 | ||||||||||||||||||||||||||
proceeds from exercise of warrants | ||||||||||||||||||||||||||||
net cash (outflows)/inflows by financing activities | ||||||||||||||||||||||||||||
net increase in cash and cash equivalents | 22,495,000 | -18,764,000 | -18,500,000 | 25,808,000 | -21,380,000 | -20,653,000 | -6,693,000 | -21,172,000 | -29,404,000 | |||||||||||||||||||
foreign exchange gains on the translation of foreign bank accounts | ||||||||||||||||||||||||||||
income taxes received / | ||||||||||||||||||||||||||||
investment in fixed assets | -37,000 | -40,000 | -34,000 | -153,000 | -153,000 | -47,000 | -7,000 | -4,000 | -99,000 | -223,000 | -936,000 | -407,000 | -81,000 | -791,000 | -693,000 | -459,000 | -153,000 | -77,000 | -90,000 | -73,000 | -39,000 | -27,000 | -37,000 | -83,000 | 4,000 | -290,000 | -42,000 | -502,000 |
net cash (outflows) in investing activities | 16,000 | 27,000 | -34,000 | -203,000 | -203,000 | -47,000 | -56,000 | -30,000 | -99,000 | -223,000 | -936,000 | -407,000 | -81,000 | -1,868,000 | -693,000 | -90,000 | -626,000 | -290,000 | -42,000 | -1,507,000 | ||||||||
proceeds from borrowings | 0 | 0 | 0 | 14,622,000 | 0 | 28,950,000 | ||||||||||||||||||||||
net cash inflows/(outflows) by financing activities | 38,757,000 | -2,541,000 | -2,012,000 | 40,298,000 | 40,298,000 | -2,571,000 | -4,340,000 | -743,000 | 38,448,000 | |||||||||||||||||||
fx (loss)/gain on the translation of foreign bank accounts | ||||||||||||||||||||||||||||
government grants and tax incentives received | 0 | 0 | 0 | 24,000 | 12,000 | 39,000 | 0 | 17,000 | ||||||||||||||||||||
income taxes received | ||||||||||||||||||||||||||||
fx gain on the translation of foreign bank accounts | ||||||||||||||||||||||||||||
fx gain/(losses) on the translation of foreign bank accounts | -56,000 | 8,000 | 75,000 | -477,000 | -2,000 | -220,000 | 1,136,000 | 501,000 | ||||||||||||||||||||
fx (loss) on the translation of foreign bank accounts | -753,000 | -753,000 | ||||||||||||||||||||||||||
• | ||||||||||||||||||||||||||||
upfront and milestone payments received | 0 | 0 | ||||||||||||||||||||||||||
payments for contingent consideration | -409,000 | 0 | -543,000 | |||||||||||||||||||||||||
net (decrease)/increase in cash and cash equivalents | -23,326,000 | -18,113,000 | ||||||||||||||||||||||||||
net decrease in cash and cash equivalents | -21,182,000 | -20,448,000 | 17,523,000 | |||||||||||||||||||||||||
payments of transaction costs from borrowings | -100,000 | 0 | -32,000 | -36,000 | -12,000 | -1,534,000 | -352,000 | |||||||||||||||||||||
income taxes | -6,000 | 0 | ||||||||||||||||||||||||||
research and development tax incentive received | 0 | 0 | 1,499,000 | 0 | 0 | 0 | 1,654,000 | |||||||||||||||||||||
income taxes (paid)/refunded | -4,000 | 0 | -3,000 | 0 | -3,000 | 0 | 0 | -1,000 | ||||||||||||||||||||
payment of lease liabilities | -524,000 | -360,000 | -335,000 | |||||||||||||||||||||||||
fx gains/(losses) on the translation of foreign bank accounts | -618,000 | |||||||||||||||||||||||||||
milestone payment received | 0 | 0 | 25,909,000 | 500,000 | 1,000,000 | 0 | 0 | |||||||||||||||||||||
net cash (outflows)/inflows in investing activities | -253,000 | -39,000 | -436,000 | |||||||||||||||||||||||||
fx (losses)/gains on the translation of foreign bank accounts | -43,000 | -143,000 | -139,000 | 96,000 | -286,000 | -879,000 | ||||||||||||||||||||||
rental deposits received | 0 | |||||||||||||||||||||||||||
interest paid | -1,123,000 | -896,000 | -887,000 | |||||||||||||||||||||||||
fx (losses) on the translation of foreign bank accounts | 56,000 | |||||||||||||||||||||||||||
payments for investments | 0 | -805,000 | ||||||||||||||||||||||||||
net proceeds from borrowings | ||||||||||||||||||||||||||||
1.3 | ||||||||||||||||||||||||||||
1.4 | ||||||||||||||||||||||||||||
1.5 | ||||||||||||||||||||||||||||
1.6 | ||||||||||||||||||||||||||||
1.7 | ||||||||||||||||||||||||||||
1.8 | ||||||||||||||||||||||||||||
1.9 | ||||||||||||||||||||||||||||
2 | ||||||||||||||||||||||||||||
2.1 | ||||||||||||||||||||||||||||
2.2 | ||||||||||||||||||||||||||||
2.3 | ||||||||||||||||||||||||||||
2.4 | ||||||||||||||||||||||||||||
2.5 | ||||||||||||||||||||||||||||
2.6 | ||||||||||||||||||||||||||||
milestone revenue received | ||||||||||||||||||||||||||||
payments for fair value adjustments to contingent consideration subsequent to the business combination measurement period | ||||||||||||||||||||||||||||
other income received | ||||||||||||||||||||||||||||
payments for financial derivatives | ||||||||||||||||||||||||||||
payments for business combination | ||||||||||||||||||||||||||||
net cash (outflows) / inflows by financing activities | -55,000 | |||||||||||||||||||||||||||
fx gains on the translation of foreign bank accounts | 590,000 | -3,536,000 | ||||||||||||||||||||||||||
payments for rental deposits | ||||||||||||||||||||||||||||
receipts from repayments of loans from employees | ||||||||||||||||||||||||||||
rent received | 22,000 |